搜索
产品
社区
市场
新闻
经纪商
更多
CN
开始
Long on ACAD - Upgraded Target to $35.00 level
做多
ACADIA Pharmaceuticals Inc.
(
NASDAQ:ACAD
)
Economist
Premium
NASDAQ:ACAD
ACADIA Pharmaceuticals Inc.
0
0
This is more of a personal play as I have been long since the stock was trading below $3.00. There is a strong possibility this recent test of support, just below the $27.00 level, initiates the continuation of the price climb.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在
使用条款
阅读更多信息。